These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28583844)

  • 1. Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells.
    Bedini A; Baiula M; Vincelli G; Formaggio F; Lombardi S; Caprini M; Spampinato S
    Biochem Pharmacol; 2017 Sep; 140():89-104. PubMed ID: 28583844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
    Hawes BE; Fried S; Yao X; Weig B; Graziano MP
    J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.
    Thomas RC; Bath MF; Stover CM; Lambert DG; Thompson JP
    Peptides; 2014 Nov; 61():56-60. PubMed ID: 25161013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mediators increase the expression of nociceptin/orphanin FQ in rat astrocytes in culture.
    Buzas B; Rosenberger J; Kim KW; Cox BM
    Glia; 2002 Sep; 39(3):237-46. PubMed ID: 12203390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
    Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G
    Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.
    Fu X; Zhu ZH; Wang YQ; Wu GC
    Neuroscience; 2007 Jan; 144(1):275-85. PubMed ID: 17069983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
    Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
    Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
    Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
    Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.
    Zhang NR; Planer W; Siuda ER; Zhao HC; Stickler L; Chang SD; Baird MA; Cao YQ; Bruchas MR
    J Biol Chem; 2012 Dec; 287(50):42019-30. PubMed ID: 23086955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
    Mandyam CD; Thakker DR; Christensen JL; Standifer KM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
    Gavioli EC; de Medeiros IU; Monteiro MC; Calo G; Romão PR
    Vitam Horm; 2015; 97():241-66. PubMed ID: 25677775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuronal circuit between nociceptin/orphanin FQ and hypocretins/orexins coordinately modulates stress-induced analgesia and anxiety-related behavior.
    Xie XS
    Vitam Horm; 2015; 97():295-321. PubMed ID: 25677777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides.
    Erdei AI; Borbély A; Magyar A; Szűcs E; Ötvös F; Gombos D; Al-Khrasani M; Stefanucci A; Dimmito MP; Luisi G; Mollica A; Benyhe S
    Peptides; 2019 Feb; 112():106-113. PubMed ID: 30513351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of small peptides as NOP and opioid receptors' ligands: view on current developments.
    Naydenova E; Todorov P; Zamfirova R
    Vitam Horm; 2015; 97():123-46. PubMed ID: 25677770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
    Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
    J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of endogenous nociceptin/orphanin FQ inhibits infarction-associated ventricular arrhythmias via PKC-dependent mechanism in rats.
    Han Y; Guo Z; Wang LL; Zhang LZ; Yao TP
    Br J Pharmacol; 2013 Oct; 170(3):614-23. PubMed ID: 23869704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.